Navigation Links
Burzynski Clinic Announces the Response to the Allegations and Complaint by the Texas Medical Board Against Dr. Burzynski
Date:1/8/2014

HOUSTON, Jan. 8, 2014 /PRNewswire/ -- The Burzynski Clinic (BC) announced today the preliminary response to the allegations in the lawsuit filed by Texas Medical Board (TMB) at the Texas State Office of Administrative Hearing on December 11, 2013 against Stanislaw R. Burzynski, M.D., Ph.D. (SRB).  The allegations claim that SRB used internet-based advertising regarding antineoplastons (ANP), and that it was false, misleading, and violated federal law.  The allegations can be divided into concerning preclinical and clinical research.  The TMB claims that the terms used by SRB for the description of the mechanism of action of ANP, such as, molecular switches that cause the death of cancer cells, but do not inhibit normal cells and that ANP are multitargeted agents, are false and misleading.  These terms were introduced in numerous publications in peer-reviewed journals and presentations at medical meetings by SRB and outside researchers, and represent findings of medical research permitted by Federal Law.

In the area of clinical research, the TMB claims the false statement that ANP treatment is limited to patients who cannot be helped by other treatments and have the worst type of cancer.  This true statement is derived from FDA supervised protocols, which restrict ANP to only such cases.  The TMB further claims that the information that 50% of children under 3 years survive over 5 years and that the clinic has patients who survived over 20 years without any sign of cancer, is false.  These statements are true and supported by data coming from clinical trials which were published in peer-reviewed journals and presented at medical meetings.  In fact, the percentage of survival at 5 years of children in this age group is 57% and currently there are 11 patients diagnosed with incurable cancer who are surviving over 20 years as a result of treatment with ANP. 
'/>"/>

SOURCE Burzynski Clinic
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Burzynski Clinic Presents the Results of Phase II Study of Antineoplastons in Children with Recurrent High-Grade Glioma at the Congress
2. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
3. Positive Clinical Study Results for BSPs HyperQ Technology
4. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
5. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
6. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
7. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
8. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
9. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
10. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
11. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/27/2014)... -- Investor-Edge has initiated coverage on the ... ), Insmed Inc. (NASDAQ: INSM ), BioCryst ... (NASDAQ: DYAX ), and Oncothyreon Inc. (NASDAQ: ... accessed at: http://investor-edge.com/register . On Friday, ... up 0.69%, the Dow Jones Industrial Average advanced 0.76%, ...
(Date:10/26/2014)... October 26, 2014 The report "Protective ... Application - Global Trends & Forecast to 2019", defines ... and forecasting of volume consumed and value generated. The ... KT in 2014 to 6,701.3 KT by 2019, at ... Browse 91 market data tables and 22 figures spread ...
(Date:10/25/2014)... Los Angeles, California (PRWEB) October 23, 2014 ... VDRM ), a specialty pharmaceutical company devoted to ... pursuing out-licensing partnerships in 2015. , ViaDerma has ... method, which allows for rapid mass transfer of ... into the body to provide immediate localized therapy. ...
(Date:10/25/2014)... (PRWEB) October 24, 2014 According ... Market by Data Center Types (Colocation, Enterprise, Telecom), ... Types (Tier 1, Tier 2, Tier 3, Tier ... MarketsandMarkets, defines and segments the Data Center Construction ... and forecasting of revenues. This research report also ...
Breaking Biology Technology:Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 2Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 3Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 4Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 5Protective Coatings Market Poised to Reach $18,431.8 Million by 2019 - Report by MarketsandMarkets 2Protective Coatings Market Poised to Reach $18,431.8 Million by 2019 - Report by MarketsandMarkets 3Protective Coatings Market Poised to Reach $18,431.8 Million by 2019 - Report by MarketsandMarkets 4ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 2Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 3Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 4
... 24 The Pittsburgh Life Sciences,Greenhouse (PLSG), ... industry on a fast track for growth, ... Innovention Technologies, LLC, a developmental-stage,medical device company, ... a,highly-maneuverable surgical probe that will alleviate the ...
... The Interstate,Alliance for Stem Cell Research should adopt a ... the Foundation for Taxpayer and,Consumer Rights (FTCR) said today., ... state,stem cell programs, is meeting today and Thursday at ... still in its early stages, it is critical to ...
... Calif., Oct. 24 Immunosyn,Corporation,s (OTC Bulletin Board: ... brokers and financial institutions at the Financial,Services Exchange ... in Phoenix, AZ on Thursday, October 25, 2007. ... and,distribution rights to SF-1019 from its largest shareholder, ...
Cached Biology Technology:The PLSG Invests $115,000 in Innovention Technologies, LLC 2Consumers Call On Interstate Stem Cell Group To Endorse Open Meetings 2Immunosyn Corporation to Present at FSX 2
(Date:10/30/2014)... news release is available in German . ... as individuals prompt our fellow humans to behave socially? ... social dilemmas in game theory. Previous studies assumed that ... groups. Nonetheless, scientists from the Max Planck Institute for ... can exert an influence on the cooperative behaviour of ...
(Date:10/30/2014)... Philadelphia, PA, October 30, 2014 – Bacteria in ... are critical for digestion. Yet, these same bacteria ... system if they penetrate the gut and enter ... natural response to protect the body, chronic or ... diseases. Prior research has established the involvement of ...
(Date:10/30/2014)... Heidelberg, 30 October 2014 Biological membranes are mainly ... of adsorption of solution ions onto lipid membranes ... a new study provides a quantitative description of ... ions. Joanna Kotyńska and Zbigniew Figaszewski from the ... a study describing these findings, just published in ...
Breaking Biology News(10 mins):Together we are strong -- or insufferable 2Together we are strong -- or insufferable 3Together we are strong -- or insufferable 4Breakdown in gut barriers to bacteria may promote inflammation and craving in alcoholics 2Ion adsorption matter in biology 2
... result of natural processes that exploited early Earth,s raw ... to minerals for such essential tasks as the synthesis ... metabolic energy. But this assumes that the mineral species ... they were during Earth,s first 550 million yearsthe Hadean ...
... size increases, so do portion size and the amount of ... how susceptible people are to this plate-size bias? New research ... and introverted children respond differently to environmental cues, such as ... examined the breakfast behaviors of kids, ages 6 to 10, ...
... discovery may help explain the surprisingly strong connections between ... Sleep loss increases the risk of Alzheimer,s ... signs of this devastating disorder. Scientists at Washington ... University of Pennsylvania have shown that brain cell damage ...
Cached Biology News:Ancient minerals: Which gave rise to life? 2Extrovert and introvert children are not equally influenced by plate size 2Broken cellular 'clock' linked to brain damage 2Broken cellular 'clock' linked to brain damage 3
... Ciphergen's ProteinChip arrays have been ... from biological samples. A variety of ... of proteins according to their unique ... different spots, allowing side-by-side sample comparison, ...
... Assay with SR-101 Labeled Substrates (red ... Accurately measure serine protease activation • ... B-Bridge's FLISP Kits utilize cell-permeable, fluorescently ... to measure chymotrypsin-like activity in whole ...
... Leu-CMK FLISP Assay with FAM-Labeled Substrate ... • Accurately measure serine protease activation ... • B-Bridge's FLISP Kits utilize cell-permeable, ... (FLISPs) to measure chymotrypsin-like activity in ...
... instrument is the cycler that revolutionized ... uniformity and swappable blocks ensure consistent ... This rugged machine is more than ... for new features and upgrades as ...
Biology Products: